UV-Reaktor
Protect your Product: UVivatec® UV virus inactivation An innovative solution for viral safety in pharmaceutical processes
- Overview of the construction of a UVivatec® module
Was wir Ihnen bieten ...
The UVivatec®-System for virus inactivation and disinfection is based on our superior UVC inactivation technology. When it comes to the treatment of biotechnological or blood- and plasma-derived products, our novel reactor design offers the best inactivation results while minimizing the damage to your valuable products.
As a superior alternative or supplement to common methods of virus reduction like heat, chemical disinfection, chromatography or filtration, the helically wound UVivatec® reactor inactivates even difficult, non-enveloped viruses like Parvovirus.
You will benefit from our new helical flow, single-use reactor with optimal hydraulic design for uniform treatment:
- first-class cross-mixing with laminar flow by Dean vortices
- narrow residence time distribution
- precise control of UVC dosage without over or underexposure
- virus inactivation without any additives
- full inactivation capabilities even at very high extinction of the fluid
- robust processing with no blocking
- no cleaning validation thanks to the single-use module concept
The system is fully scalable, from a few millilitres of sample up to continuous processing of 1,000 L/h. Parallel multi-reactor configuration is also possible for a further increase in capacity. Our systems are expected to be the most efficient, safest and cost-effective treatment systems on the market. They may also be used in the food and beverage industries and other liquid applications.
Nach oben 
Drucken 
Weiterempfehlen 
